Rössner S, Frankman O, Marsk L
Acta Obstet Gynecol Scand. 1980;59(3):255-8. doi: 10.3109/00016348009155406.
Serum lipoproteins were analyzed in 33 young women (mean age 22 years) before and after two cycles of treatment with one of the following ethinylestradiol/d-noirgestrel combinations (microgram/microgram): 30/150, 50/150 and 50/250. A slight but significant weight increase of 1.2 akg was found only in the 509/150 group. All three hormone combinations had similar effects on the lipoproteins. Before treatment all subjects had normal lipoprotein concentrations. Whole serum triglyceride (TG) and cholesterol concentrations were not significantly affected. In the whole group the LDL-TG concentration increased from 0.24 to 0.33 mmol/l (p < 0.001) and HDL-cholesterol fell from 1.54 to 1.35 mmol/l (p < 0.001). Smokers tended to have lower HDL-cholesterol than non-smokers. It is possible that HDL reductions for longer periods of time may be one of the factors that promote the development of atherosclerotic manifestations in young women on oral contraceptives.
对33名年轻女性(平均年龄22岁)在使用以下炔雌醇/炔诺孕酮组合之一(微克/微克)进行两个周期治疗前后的血清脂蛋白进行了分析:30/150、50/150和50/250。仅在50/150组中发现体重有轻微但显著的增加,增加了1.2千克。所有三种激素组合对脂蛋白的影响相似。治疗前所有受试者的脂蛋白浓度均正常。全血清甘油三酯(TG)和胆固醇浓度未受到显著影响。在整个组中,低密度脂蛋白甘油三酯(LDL-TG)浓度从0.24毫摩尔/升增加到0.33毫摩尔/升(p<0.001),高密度脂蛋白胆固醇(HDL-胆固醇)从1.54毫摩尔/升降至1.35毫摩尔/升(p<0.001)。吸烟者的HDL-胆固醇往往低于不吸烟者。长时间降低HDL可能是促进口服避孕药的年轻女性发生动脉粥样硬化表现的因素之一。